BEHRENBRUCH CHRISTIAN enters TELIX PHARMACEUTICALS LTD with 21.33M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 3/18/2026ACC: 0001628280-26-019601
DirectorOfficer· MD & Group CEO
Since Mar 2026
21.33M
Baseline shares
3% direct
654.01K
Direct ownership
2 positions
195.93K
Derivative underlying
3 instruments
3
Security positions
20.68M indirect
Non-Derivative Holdings3
American Depositary Receipts
DirectShares owned400K
Ordinary Shares
IndirectShares owned20.68M
Ordinary Shares
DirectShares owned254.01K
Total
654.01K direct·20.68M indirect21.33M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Receipts | 400K | Direct |
| Ordinary Shares | 20.68M | Indirect |
| Ordinary Shares | 254.01K | Direct |
| Total | 21.33M | 654.01K direct·20.68M indirect |
Derivative Holdings3
Share Rights
DirectUnderlying security
Ordinary Shares
Underlying shares
2.60K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Performance Share Appreciation Rights (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
93.11K
Shares owned
N/A
Exercise price
4.95
Expiration
—
Exercise window
—
Performance Share Appreciation Rights (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
100.22K
Shares owned
N/A
Exercise price
6.90
Expiration
—
Exercise window
—
Total
Underlying
195.93K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Rights Direct | Ordinary Shares | 0 | — | — | 2.60K | N/A |
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 4.95 | — | — | 93.11K | N/A |
| Performance Share Appreciation Rights (right to buy) Direct | Ordinary Shares | 6.90 | — | — | 100.22K | N/A |
| Total | 195.93K | 0.00 | ||||